Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis

Overview of attention for article published in Cardiovascular Diabetology, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#29 of 1,567)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 33 X posts from 30 X users, with an upper bound of 162,296 followers.

RT @Office_j: 【SGLT2-iには抗不整脈作用も？RCTメタ解析/ CD】 DM、CKD、HF例対象RCT 22報 [52115例] 解析：SGLT2阻害薬で、プラセボに比べ、AF検出RRは0.82 [95%CI 0.70-0.96]。塞栓性脳卒中発症は0.32…

RT @kamleshkhunti: SGLT2i ⬇️ risk of cardiac arrhythmias-meta-analysis Associated with a lower risk of AF (RR 0.82), embolic stroke (RR 0.…

RT @kamleshkhunti: SGLT2i ⬇️ risk of cardiac arrhythmias-meta-analysis Associated with a lower risk of AF (RR 0.82), embolic stroke (RR 0.…

RT @kamleshkhunti: SGLT2i ⬇️ risk of cardiac arrhythmias-meta-analysis Associated with a lower risk of AF (RR 0.82), embolic stroke (RR 0.…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 29 additional X posts.